Consensus Wave Life Sciences Ltd.

Equities

WVE

SG9999014716

Real-time Estimate Cboe BZX Other stock markets 12:16:30 2024-04-25 pm EDT			5-day change	1st Jan Change
4.77 ^USD	-4.79%		-0.10%	-5.05%

Apr. 23	Wave Life Sciences Ltd. Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing	CI
Mar. 12	Mizuho Adjusts Price Target on WAVE Life Sciences to $19 From $10, Maintains Buy Rating	MT

Evolution of the average Target Price on Wave Life Sciences Ltd.

Price target over the last 5 years

History of analyst recommendation changes

803b8.BCb_Knc0sayQKh-wbIXOk6xatKOoXGqllBfOuvxtAgE.cRC6fxpS5ObkbGXEIP-Y9O0Q4tfBO1_roU32j5RebGVXfKxPBkzn3fkfbA~2e136edcc60d576a5a28e95b05551bf2

Analyst Recommendations on Wave Life Sciences Ltd.

Mizuho Adjusts Price Target on WAVE Life Sciences to $19 From $10, Maintains Buy Rating	Mar. 12	MT
H.C. Wainwright Adjusts Price Target on WAVE Life Sciences to $15 From $8, Maintains Buy Rating	Mar. 07	MT
Leerink Partners Upgrades WAVE Life Sciences to Outperform From Market Perform, Price Target at $12	Dec. 19	MT
Raymond James Initiates WAVE Life Sciences at Outperform Rating With $7 Price Target	23-07-05	MT
Mizuho Securities Adjusts WAVE Life Sciences Price Target to $10 From $13, Maintains Buy Rating	23-05-24	MT
SVB Securities Raises Price Target on WAVE Life Sciences to $7 From $2, Maintains Market Perform Rating	22-12-14	MT
UK Unemployment Rate Expected to Increase to 5% by End of 2023	22-12-13	DJ
RBC Cuts Price Target on WAVE Life Sciences to $5 From $8, Maintains Sector Perform, Speculative Risk	22-11-11	MT
SVB Securities Adjusts Price Target on WAVE Life Sciences to $3 From $7, Maintains Market Perform Rating	22-05-13	MT
HC Wainwright Adjusts WAVE Life Sciences' Price Target to $8 from $10, Keeps Buy Rating	22-05-13	MT
Stifel Adjusts WAVE Life Sciences' Price Target to $3 From $6, Reiterates Hold Rating	22-03-04	MT
WAVE LIFE SCIENCES : Mizuho Securities Lifts Price Target on WAVE Life Sciences to $13 From $8, Citing ADAR Sales Estimates; Buy Rating Kept	21-08-12	MT
WAVE LIFE SCIENCES : Mizuho Securities Adjusts Price Target on WAVE Life Sciences to $8 From $7, Keeps Buy Rating	21-05-18	MT
WAVE LIFE SCIENCES : Mizuho Adjusts Price Target on WAVE Life Sciences to $7 From $21, Maintains Buy Rating	21-03-30	MT
WAVE LIFE SCIENCES : HC Wainwright Adjusts Price Target on WAVE Life Sciences to $10 From $20, Maintains Buy Rating	21-03-30	MT
WAVE LIFE SCIENCES : Truist Adjusts Price Target on WAVE Life Sciences to $17 From $27, Maintains Buy Rating	21-03-30	MT
WAVE LIFE SCIENCES : SVB Leerink Adjusts WAVE Life Sciences' Price Target to $7 from $10, Keeps Market Perform Rating	21-03-30	MT
-ANALYST ACTIONS : RBC Cuts Price Target on WAVE Life Sciences to $8 From $13, Maintains Sector Perform Speculative Risk	21-03-30	MT
WAVE LIFE SCIENCES : Mizuho Adjusts WAVE Life Sciences' PT to $7 From $21 on Trial Data for WVE-120102, 120101 in Huntington's Disease; Buy Rating Kept	21-03-30	MT
IONIS PHARMACEUTICALS' : Price Target From RBC Cut to $65 From $76 on Trial Discontinuation; Shares Fall Pre-Bell	21-03-23	MT
WAVE LIFE SCIENCES : Mizuho Adjusts Price Target on WAVE Life Sciences to $21 From $19, Maintains Buy Rating	21-03-10	MT
WAVE LIFE SCIENCES : HC Wainwright Starts WAVE Life Sciences at Buy With $20 Price Target	20-12-15	MT
WAVE LIFE SCIENCES : Mizuho Securities Adjusts Price Target on WAVE Life Sciences to $19 From $21, Reiterates Buy Rating	20-11-20	MT